Search by Drug Name or NDC
NDC 50090-5205-00 TRIHEXYPHENIDYL HYDROCHLORIDE 5 mg/1 Details
TRIHEXYPHENIDYL HYDROCHLORIDE 5 mg/1
TRIHEXYPHENIDYL HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is TRIHEXYPHENIDYL HYDROCHLORIDE.
MedlinePlus Drug Summary
Trihexyphenidyl is used along with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) and to control extrapyramidal symptoms (tremor, slurred speech) caused by certain medications. Trihexyphenidyl is in a class of medications called antimuscarinics. It works by relaxing muscles and nerve impulses that control the function of muscles.
Related Packages: 50090-5205-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Trihexyphenidyl
Product Information
NDC | 50090-5205 |
---|---|
Product ID | 50090-5205_808ec5d4-a0f8-4374-8a6d-e8e6b4d5bf85 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | TRIHEXYPHENIDYL HYDROCHLORIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | TRIHEXYPHENIDYL HYDROCHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/1 |
Substance Name | TRIHEXYPHENIDYL HYDROCHLORIDE |
Labeler Name | A-S Medication Solutions |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA040254 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5205-00 (50090520500)
NDC Package Code | 50090-5205-0 |
---|---|
Billing NDC | 50090520500 |
Package | 1 BOX, UNIT-DOSE in 1 BLISTER PACK (50090-5205-0) / 32 TABLET in 1 BOX, UNIT-DOSE |
Marketing Start Date | 2020-10-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |